These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23178654)

  • 1. Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway.
    Hou TC; Lin JJ; Wen HC; Chen LC; Hsu SP; Lee WS
    Biochem Pharmacol; 2013 Feb; 85(3):376-84. PubMed ID: 23178654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor.
    Lin SY; Lee WR; Su YF; Hsu SP; Lin HC; Ho PY; Hou TC; Chou YP; Kuo CT; Lee WS
    Angiogenesis; 2012 Dec; 15(4):671-83. PubMed ID: 22843228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone Inhibits Endothelial Cell Migration Through Suppression of the Rho Activity Mediated by cSrc Activation.
    Lee TS; Lin JJ; Huo YN; Lee WS
    J Cell Biochem; 2015 Jul; 116(7):1411-8. PubMed ID: 25754581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thy-1-induced migration inhibition in vascular endothelial cells through reducing the RhoA activity.
    Wen HC; Kao C; Hsu RC; Huo YN; Ting PC; Chen LC; Hsu SP; Juan SH; Lee WS
    PLoS One; 2013; 8(4):e61506. PubMed ID: 23613866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GEF-H1-RhoA signaling pathway mediates LPS-induced NF-κB transactivation and IL-8 synthesis in endothelial cells.
    Guo F; Tang J; Zhou Z; Dou Y; Van Lonkhuyzen D; Gao C; Huan J
    Mol Immunol; 2012 Feb; 50(1-2):98-107. PubMed ID: 22226472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid inhibits colorectal cancer cell migration.
    Ting PC; Lee WR; Huo YN; Hsu SP; Lee WS
    J Nutr Biochem; 2019 Jan; 63():157-164. PubMed ID: 30393128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor necrosis factor-α promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway].
    Yan CH; Yu HB; Huang MF; Li J; Zhang XL; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):531-7. PubMed ID: 21924080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GEF-H1/RhoA signalling pathway mediates lipopolysaccharide-induced intercellular adhesion molecular-1 expression in endothelial cells via activation of p38 and NF-κB.
    Guo F; Zhou Z; Dou Y; Tang J; Gao C; Huan J
    Cytokine; 2012 Mar; 57(3):417-28. PubMed ID: 22226621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway.
    Oviedo PJ; Sobrino A; Laguna-Fernandez A; Novella S; Tarín JJ; García-Pérez MA; Sanchís J; Cano A; Hermenegildo C
    Mol Cell Endocrinol; 2011 Mar; 335(2):96-103. PubMed ID: 20615453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Blk-p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion.
    Bartolomé RA; Díaz-Martínez M; Coló GP; Arellano-Sánchez N; Torres-Ayuso P; Kleinovink JW; Mérida I; Teixidó J
    Cell Signal; 2014 Nov; 26(11):2551-61. PubMed ID: 25025568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 induces the endothelial cell migration through the Rac 1/RhoA-p38MAPK pathway.
    Lai Y; Liu XH; Zeng Y; Zhang Y; Shen Y; Liu Y
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):630-8. PubMed ID: 22774404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA and Rac mediate endothelial cell polarization and detachment induced by T-cadherin.
    Philippova M; Ivanov D; Allenspach R; Takuwa Y; Erne P; Resink T
    FASEB J; 2005 Apr; 19(6):588-90. PubMed ID: 15703273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins.
    Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T
    J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines.
    Kuo CT; Lee WS
    Cancer Lett; 2016 Aug; 378(2):104-10. PubMed ID: 27233474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terbinafine inhibits endothelial cell migration through suppression of the Rho-mediated pathway.
    Ho PY; Zhong WB; Ho YS; Lee WS
    Mol Cancer Ther; 2006 Dec; 5(12):3130-8. PubMed ID: 17172416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability.
    Holinstat M; Knezevic N; Broman M; Samarel AM; Malik AB; Mehta D
    J Biol Chem; 2006 Jan; 281(4):2296-305. PubMed ID: 16308318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA.
    Varon C; Basoni C; Reuzeau E; Moreau V; Kramer IJ; Génot E
    Exp Cell Res; 2006 Nov; 312(18):3604-19. PubMed ID: 16978608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of female sex hormones on folic acid-induced anti-angiogenesis.
    Lee WS; Lu YC; Kuo CT; Chen CT; Tang PH
    Acta Physiol (Oxf); 2018 Apr; 222(4):e13001. PubMed ID: 29178430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated G(alpha)13 impairs cell invasiveness through p190RhoGAP-mediated inhibition of RhoA activity.
    Bartolomé RA; Wright N; Molina-Ortiz I; Sánchez-Luque FJ; Teixidó J
    Cancer Res; 2008 Oct; 68(20):8221-30. PubMed ID: 18922893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.